Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi Tokyo, Japan 202-8585.
Analyst. 2010 Aug;135(8):2119-24. doi: 10.1039/c0an00205d. Epub 2010 Jun 10.
Since the successful selection of fluorogenic derivatization reagent 7-chloro-N-[2-(dimethylamino)ethyl]-2,1,3-benzoxadiazole-4-sulfonamide (DAABD-Cl) as a component of a novel method (FD-LC-MS/MS method) for proteomics studies, a further reactive reagent has been required to obtain more species of proteins: DAABD-Cl reacts with only thiol moieties of proteins to give fluorescence at 505 nm with excitation at 395 nm. Here, we synthesized reagent 7-fluoro-N-[2-(dimethylamino)ethyl]-2,1,3-benzoxadiazole-4-sulfonamide, DAABD-F, having a 7-fluorine moiety instead of the 7-chlorine moiety in DAABD-Cl, expecting it to exhibit high reactivity to amino moieties of proteins. As expected, the reaction rates of low molecular thiols with DAABD-F were 50 times higher than those with DAABD-Cl. DAABD-F was able to react with the amino moiety of a low molecular amine, beta-alanine, producing fluorescence at 554 nm with excitation at 432 nm. The reaction with DAABD-F of a typical model protein, bovine serum albumin (BSA), needed a lower amount of reagent (DAABD-F) than DAABD-Cl to produce a single fluorescent derivative (fluorescence at 495 nm with excitation at 390 nm) that was demonstrated to be solely a cysteinyl residue modified product. A derivatization reaction with DAABD-F towards a soluble extract of a normal human mammary epithelial cell (HMEC) resulted in the same fluorescent protein profiles as those with DAABD-Cl except one (AHNAK nucleoprotein isoform1) that was produced by the derivatization at a lysinyl residue (4761Lys) and was identified according to the usual procedure of isolation and tryptic digestion of the fluorescent protein peak on the chromatogram and final LC-MS/MS with a database-searching algorithm.
自成功选择荧光衍生化试剂 7-氯-N-[2-(二甲氨基)乙基]-2,1,3-苯并恶二唑-4-磺酰胺(DAABD-Cl)作为一种新方法(FD-LC-MS/MS 方法)的蛋白质组学研究的组成部分以来,需要进一步的反应试剂来获得更多种类的蛋白质:DAABD-Cl 仅与蛋白质的巯基部分反应,在 395nm 激发下产生 505nm 的荧光。在这里,我们合成了试剂 7-氟-N-[2-(二甲氨基)乙基]-2,1,3-苯并恶二唑-4-磺酰胺,DAABD-F,在 DAABD-Cl 的 7-氯部分用 7-氟部分代替,预计它对蛋白质的氨基部分表现出高反应性。正如预期的那样,低分子量巯基与 DAABD-F 的反应速率比与 DAABD-Cl 的反应速率高 50 倍。DAABD-F 能够与低分子量伯胺β-丙氨酸的氨基部分反应,在 432nm 激发下产生 554nm 的荧光。与 DAABD-F 的反应需要比 DAABD-Cl 更少的试剂(DAABD-F),就可以产生单一的荧光衍生物(在 390nm 激发下产生 495nm 的荧光),该衍生物被证明仅是一个半胱氨酸残基修饰产物。对正常人类乳腺上皮细胞(HMEC)的可溶性提取物进行的 DAABD-F 衍生化反应产生的荧光蛋白谱与 DAABD-Cl 相同,除了一个(AHNAK 核蛋白同工型 1),该蛋白是在赖氨酸残基(4761Lys)处衍生化产生的,并根据色谱图上荧光蛋白峰的分离和胰蛋白酶消化以及最终使用数据库搜索算法的 LC-MS/MS 分析进行鉴定。